| Systematic (IUPAC) name | |
|---|---|
| 5,6,7,8,9,10-hexahydro-2-(4-methoxyphenyl)-cyclohepta[b]pyrazolo[3,4-d]pyridin-3(2H)-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | oral |
| Pharmacokinetic data | |
| Bioavailability | 41% |
| Identifiers | |
| CAS number | 111205-55-1 |
| ATC code | ? |
| PubChem | CID 163844 |
| Chemical data | |
| Formula | C18H19N3O2 |
| Mol. mass | 309.36236 g/mol |
| SMILES | eMolecules & PubChem |
| (what is this?) (verify) |
|
CGS-20625 is an anxiolytic drug used in scientific research. It has similar effects to, and binds to the same target as benzodiazepine drugs,[1] but is structurally distinct and so is classed as a nonbenzodiazepine anxiolytic.[2][3]
CGS-20625 produces anxiolytic and anticonvulsant effects, but with no sedative effects even at high doses, and no significant muscle relaxant effects.[4] It is orally active in humans, but with relatively low bioavailability.[5]